tiprankstipranks
Matinas BioPharma (MTNB)
NYSE MKT:MTNB

Matinas BioPharma (MTNB) Balance Sheet

1,434 Followers

Matinas BioPharma Balance Sheet

Matinas BioPharma's total assets for Q3 2023 were $29.79M, a decrease of -12.44% from the previous quarter. MTNB total liabilities were $6.64M for the fiscal quarter, a 7.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 44.82M$ 61.33M$ 70.97M$ 40.24M$ 19.94M
Total Liabilities
$ 8.18M$ 8.83M$ 7.24M$ 7.19M$ 3.80M
Total Equity Gross Minority
$ 36.64M$ 52.49M$ 63.73M$ 33.05M$ 16.14M
Total Capitalization
$ 40.19M$ 52.49M$ 63.73M$ 33.05M$ 16.14M
Preferred Stock Equity
--$ 3.80M$ 3.99M$ 9.78M
Capital Lease Obligations
--$ 3.75M$ 4.23M$ 190.90K
Currency in USD

Matinas BioPharma Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis